AI assistant
IRADIMED CORP — Director's Dealing 2021
Nov 10, 2021
32324_dirs_2021-11-10_d001e3b9-5dff-4c07-9974-9d1b7d6a4d11.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-11-05
Reporting Person: HAWKINS JAMES B (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-05 | Common Stock | A | 5501 | $1.48 | Acquired | 22769 | Direct |
| 2021-11-05 | Common Stock | S | 5501 | $38.25 | Disposed | 17268 | Direct |
| 2021-11-08 | Common Stock | A | 9479 | $1.48 | Acquired | 26747 | Direct |
| 2021-11-08 | Common Stock | S | 9479 | $38.9809 | Disposed | 17268 | Direct |
| 2021-11-09 | Common Stock | A | 1234 | $1.48 | Acquired | 18502 | Direct |
| 2021-11-09 | Common Stock | S | 1234 | $37.7501 | Disposed | 17268 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-05 | Stock Options (Right to Buy) | $1.48 | M | 5501 | Disposed | 2023-12-31 | Common Stock (5501) | Direct |
| 2021-11-08 | Stock Options (Right to Buy) | $1.48 | M | 9479 | Disposed | 2023-12-31 | Common Stock (9479) | Direct |
| 2021-11-09 | Stock Options (Right to Buy) | $1.48 | M | 1234 | Disposed | 2023-12-31 | Common Stock (1234) | Direct |
Footnotes
F1: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
F2: This transaction was executed in multiple trades at prices ranging from $38.25 to $38.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $38.60 to $39.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.